Oxepanes

eMolecules​ (7-Oxa-bicyclo[4.1.0]hept-3-yl)-carbamic acid tert-butyl ester | 1061338-92-8 | | 1g

J&W PharmLab LLC | (7-Oxa-bicyclo[4.1.0]hept-3-yl)-carbamic acid tert-butyl ester | 1g | 599147849 | 20R2258 | 98.000 | 1061338-92-8 | | 213.277 | C11H19NO3

If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool

Medchemexpress LLC 4-(5-(4,7-dimethylbenzofuran-2-yl)-1,2,4-oxadiazol-3-yl)benzoic acid | 1952276-71-9 | 98.9% | 334.33 g·mol⁻1 | C19H14N2O4 | 5 MG

Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More

KCL-286 (C286) is a potent, selective retinoic acid receptor beta-2 (RARβ2) agonist reported to be orally active and brain-penetrant (reported EC50 = 1.9 nM). It is intended for research use in in vitro and in vivo studies of retinoid signaling and neurological pharmacology. Characterization includes molecular formula C19H14N2O4, molecular weight 334.33 g·mol⁻1, and CAS 1952276-71-9.

• Potent RARβ2 agonist (EC50 = 1.9 nM).
• Orally active and brain-penetrant in reported studies.
• Suitable for in vitro and in vivo pharmacology studies.
• Characterized by molecular formula C19H14N2O4 and molecular weight 334.33 g·mol⁻1.
• Supplied as a high-purity research reagent (≈98.9% reported purity).

TARGETMOL CHEMICALS INC KCL-286 5MG

Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More

Also available in 1 mg, 10 mg, 25 mg, 50 mg, 100 mg, 200 mg and bulk. Please contact Fisher for quotes. KCL-286 is an orally available and potent retinoic acid receptor beta agonist for the amelioration of spinal cord injury (SCI). Purity 99.93%